{
  "meta": {
    "title": "95_Lymphomas",
    "url": "https://brainandscalpel.vercel.app/95-lymphomas-41047992.html",
    "scrapedAt": "2025-11-30T12:29:19.200Z"
  },
  "questions": [
    {
      "text": "What is the most common non-Hodgkin lymphoma in India?",
      "choices": [
        {
          "id": 1,
          "text": "Burkitt's lymphoma"
        },
        {
          "id": 2,
          "text": "Diffuse large B-cell lymphoma"
        },
        {
          "id": 3,
          "text": "Mantle cell lymphoma"
        },
        {
          "id": 4,
          "text": "Follicular cell lymphoma"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Diffuse large B-cell lymphoma (<strong>DLBCL</strong>) is the <strong>most common</strong> form of non-Hodgkin lymphoma (<strong>NHL</strong>) in adults and children over the age of 15 years, <strong>worldwide</strong>, and in <strong>India.</strong></p>\n<p><strong>Burkitt's </strong>lymphoma is the most common NHL in <strong>children</strong> under the age of 15 years.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9612",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not caused by the Epstein-Barr virus?",
      "choices": [
        {
          "id": 1,
          "text": "Hodgkin’s lymphoma"
        },
        {
          "id": 2,
          "text": "Primary diffuse large B cell lymphoma of the CNS"
        },
        {
          "id": 3,
          "text": "Post–organ transplant lymphoma"
        },
        {
          "id": 4,
          "text": "Primary effusion lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Human herpesvirus 8 (<strong>HHV-8</strong>) is the etiological factor for <strong>primary effusion lymphoma</strong>, not Epstein-Barr virus.</p>\n<p class=\"p1\">Lymphoid malignancies associated with <strong>Epstein-Barr virus</strong>&nbsp;include:</p>\n<ul>\n<li>Burkitt's lymphoma</li>\n<li><strong>Post-organ transplant</strong> lymphoma</li>\n<li>Primary diffuse large B cell <strong>lymphoma</strong> of the <strong>CNS</strong></li>\n<li><strong>Hodgkin's</strong> disease</li>\n<li>Extranodal NK/T cell lymphoma, nasal type</li>\n</ul>\n<p>Primary effusion lymphoma is&nbsp;a variant of diffuse large B-cell lymphoma that presents with pleural effusions, usually without apparent tumor mass lesions. It is most common in the setting of immune deficiency disease, especially AIDS.&nbsp;</p><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4105",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following types of non-Hodgkin's lymphoma and its corresponding grade are correctly matched?",
      "choices": [
        {
          "id": 1,
          "text": "Small lymphocytic lymphoma - High grade"
        },
        {
          "id": 2,
          "text": "Diffuse large B cell lymphoma - Low grade"
        },
        {
          "id": 3,
          "text": "Follicular lymphoma - Intermediate grade"
        },
        {
          "id": 4,
          "text": "Burkitt's lymphoma - High grade"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Burkitt lymphoma</strong>&nbsp;is a fast-growing,&nbsp;<strong>high-grade</strong>&nbsp;type of&nbsp;non-Hodgkin lymphoma (<wbr /><strong>NHL</strong>).</p>\n<p>NHL was earlier classified on the basis of its morphology and clinical behaviour. However, this classification is not currently used.&nbsp;Based on the clinical behavior, NHL is classified as:</p>\n<ul>\n<li>Low grade - <strong>CLL/SLL</strong> (small lymphocytic lymphoma), <strong>follicular</strong> lymphoma</li>\n<li>Intermediate grade - mantle cell and marginal cell lymphoma</li>\n<li>High grade - diffuse large B-cell lymphoma (<strong>DLBCL</strong>), Burkitt's lymphoma</li>\n</ul>\n<p>The most <strong>aggressive</strong> NHL is <strong>DLBCL</strong>, whereas the&nbsp;most<strong> rapidly progressive</strong>&nbsp;tumor is <strong>Burkitt's </strong>lymphoma.&nbsp;Most pediatric NHLs&nbsp;are&nbsp;high-grade and aggressive.</p><p>In 2023, World Lymphoma Awareness Day's theme is \"We Can&rsquo;t Wait to Focus on Our Feelings.\" This day, observed on September 15th, raises awareness about lymphatic system cancer and educates on its components: lymph nodes, spleen, thymus gland, and bone marrow. Non-Hodgkin's Lymphoma is the most common type in India, with incidence rates of 2.9/100,000 in men and 1.5/100,000 in women.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2585",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common extranodal site of involvement in patients with non-Hodgkin's lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Central nervous system"
        },
        {
          "id": 2,
          "text": "Stomach"
        },
        {
          "id": 3,
          "text": "Small intestine"
        },
        {
          "id": 4,
          "text": "Skin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The gastrointestinal tract is the most common <strong>extranodal</strong> site in patients with non-Hodgkin's lymphoma (<strong>NHL</strong>). The <strong>stomach</strong> is <strong>most commonly</strong> involved, followed by the small intestine.</p>\n<p>The skin&nbsp;is the second-most common site. <strong>Mycosis fungoides</strong> is a mature T-cell (<strong>CD4<sup>+</sup></strong>)<strong>&nbsp;</strong>NHL with skin involvement with eventual visceral and nodal spread. When malignant T-cells in the skin enter circulation, it is called <strong>Sezary syndrome.</strong>&nbsp;It presents as erythroderma (diffuse erythema and scaling). Histologically, there are&nbsp;<strong>S&eacute;zary-Lutzner </strong>cells (with&nbsp;cerebriform nuclei) and&nbsp;<strong>Pautrier </strong>microabscesses<strong>&nbsp;</strong>in epidermis.&nbsp;</p>\n<p><strong>CNS</strong>&nbsp;is the most common extranodal site in patients with&nbsp;<strong>HIV&nbsp;</strong>infection.&nbsp;Primary CNS lymphoma (histologically, DLBCL) is one of the <strong>AIDS-defining malignancies.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2560",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is used to assess the prognosis in patients with non-Hodgkin's lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Ann Arbor staging"
        },
        {
          "id": 2,
          "text": "Rai and Binet score"
        },
        {
          "id": 3,
          "text": "International Prognostic Index"
        },
        {
          "id": 4,
          "text": "Hasford scoring"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The prognosis of patients with non-Hodgkin&rsquo;s lymphoma is best assessed using the <strong>international Prognostic Index </strong>(IPI). It consists of 5 clinical risk factors for poor prognosis:</p>\n<ul>\n<li><strong>Age</strong> &gt;60 years</li>\n<li>Elevated levels of serum lactate dehydrogenase <strong>(LDH)</strong></li>\n<li><strong>Performance</strong> <strong>status</strong>&nbsp;&ge; 2 (ECOG) or&nbsp;&le;70 (Karnofsky)</li>\n<li><strong>Ann Arbor</strong>&nbsp;stage III or IV</li>\n<li>&gt;1 site of <strong>extranodal</strong> involvement</li>\n</ul>\n<p>Option A: Ann Arbor staging is used for anatomic staging to develop a treatment plan for Hodgkin's and non-Hodgkin's lymphoma.</p>\n<p>Option B: Rai and Binet score is used for&nbsp;staging of CLL.</p>\n<p>Option D: Hasford scoring is used to assess the prognosis of CML.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4108",
      "difficulty": "hard"
    },
    {
      "text": "A 63-year-old man presented with a 2-month history of fatigue, fever, and night sweats. On examination, generalized painless lymphadenopathy and splenomegaly were noted. Investigations revealed the following. What is the likely diagnosis?<div class='question-desc-html'><p>Haemoglobin - 10g/dl</p>\n<p>WBC count - 1,50,000/cu.mm</p>\n<p>Platelet count - 2,50,000/cu.mm</p>\n<p>Immunohistochemical studies - CD19+, CD20+, CD21+, C22+, CD23(-), CD 5+.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Small lymphocytic lymphoma"
        },
        {
          "id": 2,
          "text": "Follicular cell lymphoma"
        },
        {
          "id": 3,
          "text": "Burkitt's lymphoma"
        },
        {
          "id": 4,
          "text": "Mantle cell lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario is suggestive of <strong>mantle cell</strong> lymphoma. It is&nbsp;diagnosed by its characteristic immunophenotype - CD19+, CD20+, CD21+, CD22+, <strong>CD23(-), CD 5+.</strong></p>\n<p>Comparison between mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL):</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>Mantle cell lymphoma</td>\n<td>CLL/ SLL</td>\n</tr>\n<tr>\n<td><strong>CD5</strong></td>\n<td><strong>Positive</strong></td>\n<td><strong>Positive</strong></td>\n</tr>\n<tr>\n<td><strong>CD23</strong></td>\n<td><strong>Negative</strong></td>\n<td><strong>Positive</strong></td>\n</tr>\n<tr>\n<td>Cyclin D1</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>FMC7</td>\n<td>Positive</td>\n<td>Negative</td>\n</tr>\n<tr>\n<td>CD10, BCL6</td>\n<td>Negative</td>\n<td>Negative</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Brexucabtagene autoleucel, a chimeric antigen receptor T cell therapy (gene therapy) for treatment of adult patients diagnosed with mantle cell lymphoma who have not responded to or who have relapsed following other kinds of treatment. It is the first cell-based gene therapy recently approved by the FDA for the treatment of MCL.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:573,&quot;3&quot;:{&quot;1&quot;:0},&quot;5&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;6&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;7&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;8&quot;:{&quot;1&quot;:[{&quot;1&quot;:2,&quot;2&quot;:0,&quot;5&quot;:{&quot;1&quot;:2,&quot;2&quot;:0}},{&quot;1&quot;:0,&quot;2&quot;:0,&quot;3&quot;:3},{&quot;1&quot;:1,&quot;2&quot;:0,&quot;4&quot;:1}]},&quot;12&quot;:0}\">Brexucabtagene autoleucel is a chimeric antigen receptor T cell therapy. It is the first cell-based gene therapy approved for the treatment of adults diagnosed with mantle cell lymphoma. It is indicated for patients who have not responded to or who have relapsed following other kinds of treatment.&nbsp;</span></p><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2511",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrectly matched?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>   </td>\n<td>\n<p><strong>Lymphomas </strong><strong>  </strong></p>\n</td>\n<td>\n<p><strong>Cytogenetics  </strong></p>\n</td>\n</tr>\n<tr>\n<td>1.  </td>\n<td>Mantle cell lymphoma    </td>\n<td>   t (11;14)</td>\n</tr>\n<tr>\n<td>2.  </td>\n<td>Follicular lymphoma    </td>\n<td>   t (14;18)</td>\n</tr>\n<tr>\n<td>3.  </td>\n<td>Diffuse large B cell lymphoma    </td>\n<td>   t (14;18)</td>\n</tr>\n<tr>\n<td>4.  </td>\n<td>Burkitt's lymphoma  </td>\n<td>   t (18;14)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "Option 1"
        },
        {
          "id": 2,
          "text": "Option 2"
        },
        {
          "id": 3,
          "text": "Option 3"
        },
        {
          "id": 4,
          "text": "Option 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Translocations seen in <strong>Burkitt's</strong> lymphoma are <strong>t (8;14),</strong> <strong>t (2;8) and t (8;22).</strong></p><hr><h3>Related Pearl: Malignancies, Translocations and Affected Genes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Malignancy </strong></p>\n</td>\n<td>\n<p><strong>Translocation</strong></p>\n</td>\n<td>\n<p><strong>Affected Genes</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CLL/ Small lymphocytic lymphoma</p>\n</td>\n<td>\n<p>t(14;19)</p>\n</td>\n<td>\n<p><em>-</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic myelogenous leukemia (CML)</p>\n</td>\n<td>\n<p>t(9;22)</p>\n</td>\n<td>\n<p><em>ABL </em>9q34</p>\n<p><em>BCR </em>22q11</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute myeloid leukemia (AML)</p>\n</td>\n<td>\n<p>t(8; 21), t(15; 17)</p>\n</td>\n<td>\n<p><em>AML1 21</em>q22</p>\n<p><em>ETO 8</em>q22</p>\n<p><em>PML </em>15q22</p>\n<p><em>RARA </em>17q21</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Precursor B cell ALL</p>\n</td>\n<td>\n<p>t(9;22), t(4;11)</p>\n</td>\n<td>&nbsp;\n<p>BCR/ABL</p>\n<p>AF4, ALLI</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>t(8; 14), t(2;8) t(8;22)</p>\n</td>\n<td>\n<p><em>c-myc&nbsp;</em>8q24</p>\n<p><em>IGH </em>14q32</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Mantle cell lymphoma</p>\n</td>\n<td>\n<p>t(11; 14)</p>\n</td>\n<td>\n<p><em>CCND1 </em>11q13</p>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL1</em></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Follicular lymphoma</p>\n</td>\n<td>\n<p>t(14; 18)</p>\n</td>\n<td>\n<p><em>IGH </em>14q32</p>\n<p><em>BCL2 </em>18q21</p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ewing sarcoma</p>\n</td>\n<td>\n<p>t(11; 22)</p>\n</td>\n<td>\n<p><em>FLI1 </em>11q24</p>\n<p><em>EWSR1 </em>22q12</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic adenocarcinoma</p>\n</td>\n<td>\n<p>t(7; 21), t(17; 21)</p>\n</td>\n<td>\n<p><em>TMPRSS2 </em>(21q22.3)</p>\n<p><em>ETV1</em> (7p21.2)</p>\n<p><em>ETV4 </em>(17q21)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Diffuse large B-cell lymphoma</p>\n</td>\n<td>&nbsp;t(14;18)</td>\n<td>&nbsp;\n<p><em>BCL-6</em>,&nbsp;p53</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>MALT lymphoma</p>\n</td>\n<td>t(11;18)</td>\n<td><em>API2/MALT</em>, <em>BCL-10</em></td>\n</tr>\n<tr>\n<td>\n<p>CD30+ Anaplastic large cell lymphoma</p>\n</td>\n<td>t(2;5)</td>\n<td><em>ALK</em></td>\n</tr>\n<tr>\n<td>\n<p>Lymphoplasmacytoid lymphoma</p>\n</td>\n<td>t(9;14)</td>\n<td><em>PAX5, IGH</em></td>\n</tr>\n<tr>\n<td>\n<p>Synovial sarcoma</p>\n</td>\n<td>t(X;18)(p11;q11)&nbsp;</td>\n<td>&nbsp;\n<p><em>SS18-SSX2</em></p>\n<p><em>SS18-SSX4</em></p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Alveolar soft-part sarcoma</td>\n<td>&nbsp;t(X;17)(p11.2;q25)</td>\n<td>&nbsp;<em>TFE3-ASPL</em></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2522",
      "difficulty": "medium"
    },
    {
      "text": "A 59-year-old came to the OPD after noticing a swelling on her neck. On examination, painless lymphadenopathy was noted in the cervical, axillary and inguinal regions with no hepatosplenomegaly. CBC was normal. Lymph node biopsy showed effacement of nodal architecture with centrocytes and centroblasts. Which of the following immunophenotypic panels will confirm this diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "CD19, CD 23, CD5"
        },
        {
          "id": 2,
          "text": "CD19,  CD22, CD5"
        },
        {
          "id": 3,
          "text": "CD19, CD79a, CD10, TdT"
        },
        {
          "id": 4,
          "text": "CD 19, CD79a, CD 20, CD10, CD 23, Bcl-2"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This clinical scenario and the presence of centrocytes and centroblasts on biopsy are suggestive of <strong>follicular lymphoma.&nbsp;</strong>Immunophenotyping will be positive for&nbsp;CD<strong>19</strong>, CD<strong>79a</strong>, CD<strong>20</strong>, CD<strong>10</strong>, CD<strong>23</strong>, <strong>Bcl-2</strong>.</p>\n<p>Follicular lymphoma presents at a median age of 59 years with no sex predilection. The patients most commonly develop <strong>painless</strong> <strong>generalized</strong> <strong>lymphadenopathy</strong>. Systemic symptoms are absent. A lymph node biopsy is usually adequate for the diagnosis of follicular lymphoma. Characteristic features following lymph node <strong>biopsy</strong> include:</p>\n<ul>\n<li>The normal nodal architecture is effaced by nodular expansions of tumour cells</li>\n<li><strong>Centrocytes</strong>&nbsp;- small lymphocytes with cleaved nuclei</li>\n<li><strong>Centroblasts</strong>&nbsp;- larger cells with vesicular chromatin and prominent nucleoli</li>\n</ul><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2539",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false about diffuse large B-cell lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "It is a high-grade aggressive lymphoma"
        },
        {
          "id": 2,
          "text": "It is commonly associated with BCL-6 chromosomal rearrangements"
        },
        {
          "id": 3,
          "text": "It is associated with CNS lymphoma and intravascular lymphoma"
        },
        {
          "id": 4,
          "text": "It does not present with extranodal involvement"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Diffuse large B-cell lymphoma (<strong>DLBCL</strong>) commonly&nbsp;(<strong>&gt;50%</strong>) presents with <strong>extranodal</strong> involvement at diagnosis, with the most common sites being the <strong>GI tract</strong> and <strong>bone marrow</strong>.</p>\n<p>DLBCL is the most common non-Hodgkin's lymphoma. It is a <strong>high-grade</strong> <strong>aggressive</strong> tumour. It is associated with <strong>BCL-6</strong> chromosomal rearrangements and&nbsp;<strong>t(14;18).&nbsp;</strong>It is commonly associated with CNS lymphoma, pleural effusion lymphoma, and intravascular lymphoma. It is considered an<strong>&nbsp;AIDS-defining</strong>&nbsp;malignancy.</p>\n<p>AIDS-defining&nbsp;malignancies include:</p>\n<ul>\n<li>Kaposi sarcoma</li>\n<li>Primary central nervous system lymphoma (DLBCL)</li>\n<li>Non-Hodgkin's lymphoma</li>\n<li>Invasive cervical cancer</li>\n</ul><p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;The FDA recently approved Lisocabtagene maraleucel, a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:1,&quot;3&quot;:{&quot;1&quot;:0}}\">The FDA recently approved <strong>Lisocabtagene maraleucel</strong>, a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2548",
      "difficulty": "easy"
    },
    {
      "text": "A physician is in Africa, working with the Doctors Without Borders group. He encounters a 7-year-old boy with the following finding. His parents say that he had a jaw swelling for 2 months that failed to resolve with antibiotics. A biopsy of the swelling reveals a starry sky appearance. Which of the following statements is true about this patient's condition?",
      "choices": [
        {
          "id": 1,
          "text": "It is associated with n-myc dysregulation"
        },
        {
          "id": 2,
          "text": "Tumor cells show CD21 expression"
        },
        {
          "id": 3,
          "text": "Expectant management is the treatment of choice"
        },
        {
          "id": 4,
          "text": "It is associated with HIV infection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario is suggestive of the <strong>endemic</strong> type of <strong>Burkitt's lymphoma</strong>. In this condition, the tumor cells are <strong>CD21+</strong>.</p>\n<p>Burkitt's lymphoma is an <strong>aggressive</strong> condition and is the most common NHL in children. This condition is endemic in <strong>African</strong> countries and is associated with Epstein-Barr virus (<strong>EBV</strong>) <strong>infection</strong>. It is associated with <strong>c-myc</strong> dysregulation, especially in cases in bone marrow involvement.</p>\n<p>Patients require aggressive management with <strong>high-dose chemotherapy.</strong></p><hr><h3>Related Pearl: Burkitt's Lymphoma</h3><p>Burkitt's lymphoma is the most common non-Hodgkin's lymphoma in children &lt; 15 years.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;Parameter</td>\n<td>&nbsp;Features</td>\n</tr>\n<tr>\n<td>Genetic factors</td>\n<td>\n<p>Translocations -&nbsp;t(8;14), t(2;8), t(8,22)</p>\n</td>\n</tr>\n<tr>\n<td>Clinical types</td>\n<td>\n<p><strong>Endemic -</strong>&nbsp;affects children in Africa, affects jaw, maxilla and is EBV-associated</p>\n<p><strong>Sporadic -</strong>&nbsp;in adults in western countries&nbsp;</p>\n<p><strong>Immunodeficiency </strong>associated<strong> -</strong>&nbsp;HIV infection</p>\n</td>\n</tr>\n<tr>\n<td>Clinical features</td>\n<td>\n<p>Peripheral lymphadenopathy</p>\n<p>Intrabdominal mass</p>\n<p>Rapid CNS metastasis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Histology</td>\n<td>\n<p>Starry sky pattern</p>\n<p>Ki-67 stains for 100% of cells (due to&nbsp;rapid proliferation)</p>\n</td>\n</tr>\n<tr>\n<td>Immunophenotype</td>\n<td>\n<p><strong>B cell</strong>-associated antigens (CD19, CD20, CD22, CD79a)</p>\n<p><strong>Germinal center</strong>-associated markers (CD10 &amp; BCL-6)</p>\n<p>CD<strong>43</strong>,&nbsp;<strong>BCL-2</strong>&nbsp;in up to 20% of cases</p>\n<p>Expression of CD21 (the&nbsp;<span class=\"nowrap\">EBV/C3d</span>&nbsp;receptor) depends on EBV status of the tumors:</p>\n<ul>\n<li><strong>Endemic</strong> type<strong>&nbsp;</strong>(EBV+) -&nbsp;<strong>CD21</strong></li>\n<li>Non-endemic&nbsp;type (EBV-) - lack CD21</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Treatment</td>\n<td>\n<p>Started immediately after diagnosis</p>\n<p>Intensive chemotherapy regimens with high doses of cyclophosphamide</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Prognosis</td>\n<td>&nbsp;Good -&nbsp;70-80% cure rate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A variant of this condition with bone marrow involvement is called Burkitt's leukemia (<strong>ALL-L3</strong>). It is associated with <strong>c-myc</strong> dysregulation.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6f1af4ec25574db1a3d7ec2b1c0c8609.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2605",
      "difficulty": "hard"
    },
    {
      "text": "The lymph node biopsy of a patient with lymphoma is given below. It shows two different cell populations labeled as A and B. Which of the following statements is false?",
      "choices": [
        {
          "id": 1,
          "text": "Cells labelled A will test positive for CD14, CD40, CD11b & CD64"
        },
        {
          "id": 2,
          "text": "The fraction of cells with positive Ki67 staining is 100%"
        },
        {
          "id": 3,
          "text": "Cells labelled B will test positive for CD19, CD10, BCL-6 & CD43"
        },
        {
          "id": 4,
          "text": "Cells labelled B represent the stars in starry sky appearance"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image shows the characteristic <strong>starry sky</strong> appearance of <strong>Burkitt's</strong> <strong>lymphoma</strong>. The <strong>reactive macrophages</strong> (labelled as A) represent the <strong>stars</strong> in starry sky appearance. On the other hand, the homogenous tumour cells (labelled as B) represent the sky.</p>\n<p>The neoplastic cells are homogeneous, <strong>medium-sized B cells</strong> with a high growth fraction. These cells are positive for&nbsp;CD19, CD10, BCL-6 &amp; CD43.</p>\n<p>Reactive macrophages are scattered throughout the tumour. Their <strong>pale cytoplasm</strong> in a background of blue-staining tumour cells gives the tumor a so-called starry sky appearance.<strong>&nbsp;</strong>Reactive leukocytes and macrophages are not stained by special stains. They are positive for&nbsp;CD14, CD40, CD11b &amp; CD64.</p>\n<p>The growth fraction of these lymphomas is very high, with frequent<strong> mitotic figures</strong>. The fraction of <strong>Ki-67+</strong> (MIB-1+) stained cells is nearly <strong>100%</strong>.</p><hr><h3>Related Pearl: Burkitt's Lymphoma</h3><p>Burkitt's lymphoma is the most common non-Hodgkin's lymphoma in children &lt; 15 years.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;Parameter</td>\n<td>&nbsp;Features</td>\n</tr>\n<tr>\n<td>Genetic factors</td>\n<td>\n<p>Translocations -&nbsp;t(8;14), t(2;8), t(8,22)</p>\n</td>\n</tr>\n<tr>\n<td>Clinical types</td>\n<td>\n<p><strong>Endemic -</strong>&nbsp;affects children in Africa, affects jaw, maxilla and is EBV-associated</p>\n<p><strong>Sporadic -</strong>&nbsp;in adults in western countries&nbsp;</p>\n<p><strong>Immunodeficiency </strong>associated<strong> -</strong>&nbsp;HIV infection</p>\n</td>\n</tr>\n<tr>\n<td>Clinical features</td>\n<td>\n<p>Peripheral lymphadenopathy</p>\n<p>Intrabdominal mass</p>\n<p>Rapid CNS metastasis&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Histology</td>\n<td>\n<p>Starry sky pattern</p>\n<p>Ki-67 stains for 100% of cells (due to&nbsp;rapid proliferation)</p>\n</td>\n</tr>\n<tr>\n<td>Immunophenotype</td>\n<td>\n<p><strong>B cell</strong>-associated antigens (CD19, CD20, CD22, CD79a)</p>\n<p><strong>Germinal center</strong>-associated markers (CD10 &amp; BCL-6)</p>\n<p>CD<strong>43</strong>,&nbsp;<strong>BCL-2</strong>&nbsp;in up to 20% of cases</p>\n<p>Expression of CD21 (the&nbsp;<span class=\"nowrap\">EBV/C3d</span>&nbsp;receptor) depends on EBV status of the tumors:</p>\n<ul>\n<li><strong>Endemic</strong> type<strong>&nbsp;</strong>(EBV+) -&nbsp;<strong>CD21</strong></li>\n<li>Non-endemic&nbsp;type (EBV-) - lack CD21</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Treatment</td>\n<td>\n<p>Started immediately after diagnosis</p>\n<p>Intensive chemotherapy regimens with high doses of cyclophosphamide</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Prognosis</td>\n<td>&nbsp;Good -&nbsp;70-80% cure rate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A variant of this condition with bone marrow involvement is called Burkitt's leukemia (<strong>ALL-L3</strong>). It is associated with <strong>c-myc</strong> dysregulation.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3f454d919629410a81c95eb4a556444f.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4110",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following conditions are at risk of developing salivary gland MALToma?",
      "choices": [
        {
          "id": 1,
          "text": "Helicobacter pylori gastritis"
        },
        {
          "id": 2,
          "text": "Hashimoto’s thyroiditis"
        },
        {
          "id": 3,
          "text": "Sjogren's syndrome"
        },
        {
          "id": 4,
          "text": "Celiac disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Sjogren's syndrome</strong> is&nbsp;implicated in <strong>salivary gland MALToma</strong>.</p>\n<p>MALT lymphomas are commonly associated with an underlying <strong>autoimmune or inflammatory</strong> process such as:</p>\n<ul>\n<li>Sjogren&rsquo;s syndrome - salivary gland&nbsp;</li>\n<li>Hashimoto&rsquo;s thyroiditis - thyroid&nbsp;</li>\n<li><em>Helicobacter pylori</em> gastritis - gastric (most common)</li>\n<li>Celiac disease - small intestine</li>\n</ul>\n<p>The most common translocation associated with MALToma is<strong> (11,18)</strong>. It has a good prognosis.</p><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4109",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a T-cell lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Hairy cell leukemia"
        },
        {
          "id": 2,
          "text": "Mycosis fungoides"
        },
        {
          "id": 3,
          "text": "Anaplastic large cell lymphoma"
        },
        {
          "id": 4,
          "text": "Null cell lymphoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Hairy cell</strong> leukemia arises from a late, activated memory <strong>B cell</strong> exhibiting post-germinal center features.</p>\n<p><strong>Mycosis fungoides</strong> and <strong>a</strong><strong>naplastic large cell </strong>lymphoma (also called <strong>n</strong><strong>ull cell </strong>lymphoma) are both <strong>T-cell </strong>lymphomas.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2683",
      "difficulty": "medium"
    },
    {
      "text": "The peripheral smear of a patient who presented with generalized lymphadenopathy and hepatosplenomegaly is given below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Mantle cell lymphoma"
        },
        {
          "id": 2,
          "text": "Peripheral T cell lymphoma"
        },
        {
          "id": 3,
          "text": "Anaplastic large cell lymphoma"
        },
        {
          "id": 4,
          "text": "Adult T cell leukemia/lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given peripheral smear shows tumor cells with <strong>multilobulated nuclei</strong> called <strong>cloverleaf</strong> or <strong>flower</strong> <strong>cells</strong>. This is characteristic of <strong>adult T-Cell leukemia/lymphoma.</strong></p>\n<p>This condition occurs in adults infected by human T-cell leukemia retrovirus type 1 (<strong>HTLV-1</strong>).<strong>&nbsp;</strong>It is&nbsp;a rapidly progressive disease that is fatal within months to one year following diagnosis<strong>.&nbsp;</strong>It is characterized by the following clinical features:</p>\n<ul>\n<li>Skin lesions</li>\n<li>Generalized lymphadenopathy</li>\n<li>Hepatosplenomegaly</li>\n<li>Peripheral blood lymphocytosis,</li>\n<li>Hypercalcemia</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2f8ed0363b2c4c9597af09deb0bae4d2.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2247",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old man presented with fatigue and dragging sensation in the left upper abdomen. Physical examination revealed massive splenomegaly and no lymphadenopathy. CBC revealed pancytopenia. Bone marrow aspirate yielded a dry tap. Immunohistochemical staining of the tumor cells tested positive for CD19, CD22, CD11c, CD25, CD103 and CD123. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Myelofibrosis"
        },
        {
          "id": 2,
          "text": "Splenic marginal zone lymphoma"
        },
        {
          "id": 3,
          "text": "Multiple myeloma"
        },
        {
          "id": 4,
          "text": "Hairy cell leukemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>This clinical scenario is suggestive of <strong>hairy cell leukemia&nbsp;</strong>(HCL).</p>\n<p>In this condition, most patients present with symptoms related to&nbsp;<strong>cytopenias</strong> or <strong>splenomegaly</strong>. On bone marrow aspiration, a&nbsp;<strong>dry tap</strong> is obtained due to HCL-induced marrow fibrosis and the interlocking cell borders of hairy cells (distinct from myelofibrosis).</p>\n<p>Tumor cells share certain characteristics of memory B cells.<strong> CD11c, CD25, CD103, CD123</strong> is the characteristic immunophenotype diagnostic of this condition. Pan-B markers such as&nbsp;<strong>CD19, CD20, and CD22</strong> may also be positive.</p>\n<p>Note: Splenic marginal zone lymphoma involves <strong>both white</strong><strong>&nbsp;</strong>and<strong> red pulp</strong> of the spleen, whereas hairy cell leukemia is limited to the red pulp.&nbsp;All non-Hodgkin's lymphomas involve white pulp of spleen except:</p>\n<ul>\n<li>Hairy cell leukemia</li>\n<li>Hepatosplenic lymphoma</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2693",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following best distinguishes hairy cell leukemia from other B cell malignancies?",
      "choices": [
        {
          "id": 1,
          "text": "Hairy cells on a Wright-stained peripheral blood smear"
        },
        {
          "id": 2,
          "text": "Annexin A1 on bone marrow specimens"
        },
        {
          "id": 3,
          "text": "Positive tartarate-resistant acid phosphatase stain"
        },
        {
          "id": 4,
          "text": "Intracytoplasmic inclusion bodies called ribosome-lamellar complexes"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Annexin A1</strong> on <strong>immunophenotyping</strong> of bone marrow specimens is the best method to <strong>differentiate</strong> <strong>hairy cell</strong> leukemia from <strong>other B-cell</strong> malignancies. It&nbsp;has 100% sensitivity and specificity.</p>\n<p><strong>Hairy cells</strong> on&nbsp;Wright-stained peripheral blood smear are an important diagnostic finding. Typical<strong> hairy cells</strong>&nbsp;are mononuclear cells&nbsp;with abundant pale<strong> blue-grey agranular </strong>cytoplasm with elongated (hairy) projections. Intracytoplasmic inclusion bodies called <strong>ribosome-lamellar</strong> <strong>complexes</strong> can also be seen in 50% of cases. However, these can be seen in other B-cell disorders also.</p>\n<p>Tartrate-resistant acid phosphatase (<strong>TRAP</strong>)<strong> stain</strong> is an important tool and is positive in 95% of cases of hairy cell leukemia. However, it is not pathognomonic.</p><p>The following pattern of<strong> bone marrow</strong> involvement is near to pathognomonic for hairy cell leukemia (&gt;99%):</p>\n<ul>\n<li>Diffuse infiltration of tumor cells with&nbsp;<strong>honeycomb</strong>&nbsp;appearance.</li>\n<li>Individual cells have a <strong>fried egg</strong>&nbsp;appearance such that the nucleus of each hairy cell is surrounded by a halo of cytoplasm, as shown below.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/61cb819485da4260b0f793724266e5a1x800x533.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2702",
      "difficulty": "hard"
    },
    {
      "text": "Patients with hairy-cell leukemia are at a higher risk of infection with which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Parvovirus B19"
        },
        {
          "id": 2,
          "text": "Mycoplasma pneumoniae"
        },
        {
          "id": 3,
          "text": "Mycobacterium avium intracellulare"
        },
        {
          "id": 4,
          "text": "Cryptococcus neoformans"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hairy cell leukemia</strong> is associated with infections of <strong><em>Mycobacterium avium-intracellulare</em></strong>.&nbsp;This is possibly related to frequent unexplained <strong>monocytopenia</strong>. Among them, infection with <em>Mycobacterium kansasii</em>&nbsp;is common.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0192",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old man presented with progressive fatigue and weight loss for 3 months. CBC showed pancytopenia. On peripheral smear, the following cells were seen, which also showed positive staining with TRAP. What is the drug of choice for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vemurafenib"
        },
        {
          "id": 2,
          "text": "Pentostatin"
        },
        {
          "id": 3,
          "text": "Interferon α"
        },
        {
          "id": 4,
          "text": "Cladribine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given image shows <strong>mononuclear cells</strong>&nbsp;with abundant pale<strong> blue-grey agranular </strong>cytoplasm with elongated (<strong>hairy</strong>) <strong>projections</strong>,<strong>&nbsp;</strong>which are&nbsp;<strong>TRAP</strong>-<strong>positive</strong>. This&nbsp;clinical scenario is suggestive of <strong>hairy cell leukemia.&nbsp;</strong>The&nbsp;drug of choice is&nbsp;<strong>cladribine.</strong></p>\n<p>Hairy cell leukemia is responsive to chemotherapy with interferon &alpha;, pentostatin, and cladribine. However, cladribine is the preferred drug of choice due to <strong>complete remission</strong> in the majority of patients, and higher rates of <strong>long-term</strong> disease-free <strong>survival</strong>.&nbsp;It is administered daily for 7 days by continuous intravenous infusion.</p>\n<p>Chemotherapy-refractory patients have&nbsp;responded to <strong>vemurafenib</strong>, a BRAF inhibitor.&nbsp;Splenectomy is often&nbsp;associated with prolonged remission.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a428add7718246468f1e6d3e15155bfd.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2708",
      "difficulty": "medium"
    },
    {
      "text": "What subtype of Hodgkin's lymphoma is most commonly seen in India?",
      "choices": [
        {
          "id": 1,
          "text": "Nodular sclerosing"
        },
        {
          "id": 2,
          "text": "Mixed cellularity classical"
        },
        {
          "id": 3,
          "text": "Lymphocyte-rich classical"
        },
        {
          "id": 4,
          "text": "Lymphocyte depleted classical"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The most common subtype of Hodgkin's lymphoma in<strong> India</strong> is the <strong>mixed cellularity</strong> classical Hodgkin's lymphoma. In contrast,&nbsp;<strong>nodular sclerosis</strong>&nbsp;is most commonly seen in&nbsp;<strong>western </strong>countries.</p>\n<p>The&nbsp;most common subtype of <strong>Hodgkin's lymphoma</strong> in:</p>\n<ul>\n<li>Developed/ western countries - nodular sclerosing&nbsp;</li>\n<li>Children - mixed cellularity</li>\n<li>Females - nodular sclerosis (but Hodgkin's lymphoma is more common in males overall)</li>\n<li>HIV-associated - mixed cellularity</li>\n<li>EBV-associated - lymphocyte-depleted&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4104",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not a classical form of Hodgkin lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Nodular sclerosing"
        },
        {
          "id": 2,
          "text": "Lymphocyte depleted"
        },
        {
          "id": 3,
          "text": "Nodular lymphocyte predominant"
        },
        {
          "id": 4,
          "text": "Lymphocyte-rich"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Nodular</strong> <strong>lymphocyte</strong>-<strong>predominant</strong> Hodgkin's lymphoma (HL) is a <strong>distinct</strong> clinicopathological entity <strong>from classical</strong> Hodgkin lymphoma as per the WHO classification.</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Classical HL&nbsp;</strong></td>\n<td><strong>Nodular lymphocyte-predominant HL</strong></td>\n</tr>\n<tr>\n<td>Subtypes</td>\n<td>\n<ul>\n<li>Nodular sclerosis&nbsp;</li>\n<li>Mixed cellularity</li>\n<li>Lymphocyte-rich&nbsp;</li>\n<li>Lymphocyte depleted&nbsp;</li>\n</ul>\n</td>\n<td>-&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;Key difference</td>\n<td>Do not express many of the genes that define normal B cells</td>\n<td>Retain the immunophenotypic features of germinal center B cells</td>\n</tr>\n<tr>\n<td>&nbsp;Immunophenotype</td>\n<td>\n<p>&nbsp;<strong>CD15+ CD30+</strong></p>\n<p>CD20- &nbsp;CD45-</p>\n</td>\n<td>\n<p><strong>CD20+ CD45+&nbsp;</strong></p>\n<p>CD15- &nbsp;CD30-</p>\n</td>\n</tr>\n<tr>\n<td>Neoplastic cell</td>\n<td><strong>Reed-Sternberg</strong> cell&nbsp;</td>\n<td><strong>Popcorn</strong> cell or L&amp;H&nbsp;(lymphocytic &amp; histiocytic)&nbsp;cells&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;Common Presentation</td>\n<td>Mediastinal lymphadenopathy</td>\n<td>Peripheral lymphadenopathy</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>The following image shows the Reed-Sternberg cell in classic HL.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ac1824ee43024c86bb1b9a93343a906ax731x599.JPEG\" alt=\"Explanation Image\"><p>The following image shows the popcorn cell in nodular lymphocyte-predominant HL.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1ab94888362a4102b1a3718cbda36e3ax1280x930.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4115",
      "difficulty": "easy"
    },
    {
      "text": "What is the most commonly observed clinical presentation in patients with Hodgkin's lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Supraclavicular lymphadenopathy"
        },
        {
          "id": 2,
          "text": "Axillary lymphadenopathy"
        },
        {
          "id": 3,
          "text": "Hepatosplenomegaly"
        },
        {
          "id": 4,
          "text": "Mediastinal mass"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Supraclavicular</strong> or <strong>cervical</strong> lymphadenopathy is the <strong>most common</strong> clinical presentation of <strong>Hodgkin's lymphoma</strong>.</p>\n<p>The clinical features of Hodgkin's lymphoma are as follows:</p>\n<ul>\n<li><strong>Asymptomatic</strong> <strong>lymphadenopathy</strong> (<strong>non-tender</strong> with a <strong>rubbery </strong>consistency) is the most common presentation.&nbsp;\n<ul>\n<li>Most common - cervical or supraclavicular</li>\n<li>Second-most common presentation - <strong>mediastinal</strong> mass</li>\n</ul>\n</li>\n<li><strong>Hepatosplenomegaly</strong> in some cases</li>\n<li>Pel-Ebstein fever:\n<ul>\n<li>Refers to recurrent febrile and afebrile intervals, each phase lasting for days to weeks</li>\n<li>More common in older patients with mixed-cellularity Hodgkin&rsquo;s lymphoma in an abdominal site</li>\n</ul>\n</li>\n<li>Alcohol-induced pain is a rare, unusual presentation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2813",
      "difficulty": "medium"
    },
    {
      "text": "A 29-year-old man with a 3-week history of fever is found to have multiple rubbery, enlarged lymph nodes. A biopsy reveals abnormal cells with bilobed nuclei that are positive for CD15 and CD30. Which of the following is associated with this man's condition?",
      "choices": [
        {
          "id": 1,
          "text": "Syndrome of inappropriate ADH secretion"
        },
        {
          "id": 2,
          "text": "Lambert-Eaton syndrome"
        },
        {
          "id": 3,
          "text": "Subacute cerebellar degeneration"
        },
        {
          "id": 4,
          "text": "Superficial migratory thrombophlebitis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This clinical scenario is suggestive of <strong>Hodgkin's lymphoma</strong>. The <strong>paraneoplastic</strong> syndrome associated with this condition is <strong>subacute cerebellar degeneration</strong>.</p>\n<p>Other paraneoplastic syndromes associated with Hodgkin's lymphoma include:</p>\n<ul>\n<li>Minimal change disease (nephrotic syndrome)</li>\n<li>Vanishing bile duct syndrome</li>\n<li>Cholangitis</li>\n<li>Alcohol-induced pain -&nbsp;pain typically occurs within a few minutes after the ingestion of even a small amount of alcohol and is localized to areas involved by HL</li>\n</ul>\n<p>Option A: Syndrome of inappropriate ADH secretion is associated with small cell lung carcinoma of the lungs.</p>\n<p>Option B: Lambert-Eaton syndrome is associated with small cell lung carcinoma of the lungs.</p>\n<p>Option D: Migratory superficial thrombophlebitis (Trousseau syndrome) is associated with adenocarcinoma of the pancreas&nbsp;and lungs.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4118",
      "difficulty": "medium"
    },
    {
      "text": "The lymph node biopsy of a 49-year-old woman with painless lymphadenopathy revealed the following finding. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Lymphocyte-depleted Hodgkin's lymphoma"
        },
        {
          "id": 2,
          "text": "Lymphocyte-rich Hodgkin's lymphoma"
        },
        {
          "id": 3,
          "text": "Nodular sclerosis Hodgkin's lymphoma"
        },
        {
          "id": 4,
          "text": "Mixed cellularity Hodgkin's lymphoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image shows a <strong>lacunar</strong> <strong>Reed-Sternberg</strong> (RS) cell. It is identified by a folded or multilobed nucleus surrounded by an <strong>open space</strong>, which is an artifact created by disruption of the cytoplasm during tissue sectioning. It is seen in <strong>nodular sclerosis</strong> classical Hodgkin's disease (CHL).</p><p>The histological subtypes of classical Hodgkin's disease are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>Subtype</td>\n<td>Histopathology</td>\n<td>Clinical correlation</td>\n</tr>\n<tr>\n<td>Nodular sclerosis</td>\n<td>\n<p>Lacunar RS cell</p>\n<p>Necrosis with inflammatory infiltrate (eosinophils, macrophages, plasma cells)</p>\n<p>Fibrous bands dividing cellular areas into nodules</p>\n</td>\n<td>\n<ul>\n<li>Mediastinal lymphadenopathy and superior vena cava syndrome&nbsp;</li>\n<li><strong>Excellent prognosis</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Mixed cellularity</td>\n<td>RS cells with rich inflammatory infiltrate</td>\n<td>\n<ul>\n<li>Biphasic: Children and elderly</li>\n<li>B symptoms</li>\n<li>Associated with EBV (and HIV)</li>\n<li>Very good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Lymphocyte-rich</td>\n<td>Background infiltrate rich<br />in T-cells</td>\n<td>-&nbsp;</td>\n</tr>\n<tr>\n<td>Lymphocyte- depleted</td>\n<td>Reticular variant, paucity of background reactive cells</td>\n<td>\n<ul>\n<li>Associated with HIV (and EBV)</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/eebf12b263484254b267443f6f49fa2a.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4120",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true about Hodgkin's lymphoma?",
      "choices": [
        {
          "id": 1,
          "text": "Reed-Sternberg cell is specific for Hodgkin's disease"
        },
        {
          "id": 2,
          "text": "Classical Hodgkin's lymphoma is associated with CD20 positive cells"
        },
        {
          "id": 3,
          "text": "Central nervous system is the most common site of extranodal disease"
        },
        {
          "id": 4,
          "text": "PET-CT is the most reliable technique for staging Hodgkin's lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>PET-CT</strong> is the <strong>most reliable</strong> technique for <strong>staging</strong> <strong>Hodgkin's</strong> lymphoma.</p>\n<p><strong>Reed-Sternberg</strong> cells on histology, point to a clinical diagnosis of Hodgkin's lymphoma. However, they are <strong>not specific</strong> for Hodgkin's lymphoma. Reed-Sternberg cells can also be seen in the following conditions:</p>\n<ul>\n<li>Infectious mononucleosis&nbsp;</li>\n<li>Solid tissue cancers</li>\n<li>Large cell non-Hodgkin's lymphomas (most common in immunoblastic type)</li>\n</ul>\n<p><strong>Classical</strong> Hodgkin's lymphoma is associated with positive test results for <strong>CD15</strong> and <strong>CD30</strong>. Nodular lymphocyte-predominant Hodgkin's lymphoma is associated with CD20 positive cells.</p>\n<p>The central nervous system (<strong>CNS</strong>) is an <strong>uncommon</strong> <strong>site</strong> of extranodal disease in Hodgkin's lymphoma. Lung, liver, bone, and bone marrow are the most common extranodal sites for the disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2840",
      "difficulty": "medium"
    },
    {
      "text": "A 68-year-old man presented with fever, night sweats, and weight loss for 2 months. On examination,  non-tender, rubbery lymph nodes were palpable in the supraclavicular and inguinal regions on both sides. Biopsy showed the presence of Reed-Sternberg cells. How would you stage this patient according to the Ann Arbor Staging?",
      "choices": [
        {
          "id": 1,
          "text": "Stage IIA"
        },
        {
          "id": 2,
          "text": "Stage IIB"
        },
        {
          "id": 3,
          "text": "Stage IIIA"
        },
        {
          "id": 4,
          "text": "Stage IIIB"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In this scenario of Hodgkin's lymphoma, the patient presented with <strong>B symptoms </strong>(fever, night sweats, and weight loss) and shows lymph node involvement on <strong>both sides</strong> of the <strong>diaphragm</strong> are involved (supraclavicular and inguinal). According to Ann Arbor Staging, this patient is categorized as&nbsp;<strong>stage IIIB</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Ann Arbor Staging of Hodgkin's lymphoma</strong></td>\n</tr>\n<tr>\n<td>\n<p>Stage I</p>\n</td>\n<td>\n<p>Involvement of a <strong>single</strong> lymph node (I) or a single extra-lymphatic organ or site (IE)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage II</p>\n</td>\n<td>\n<p>Involvement of 2 or more lymph node regions on the <strong>same side of the diaphragm</strong> (II) or localized involvement of an extra-lymphatic organ or site and 1 or more lymph node regions on the same side of the diaphragm (IIE)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage III</p>\n</td>\n<td>\n<p>Involvement of lymph node regions on <strong>both sides of the </strong><strong>diaphragm </strong>(III), which may be accompanied by:</p>\n<ul>\n<li>Involvement of the spleen (IIIS) [or]</li>\n<li>Localized involvement of an extra-lymphatic organ or site (IIIE) [or]</li>\n<li>Both (IIISE)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage IV</p>\n</td>\n<td>\n<p><strong>Diffuse</strong> or disseminated involvement of 1 or more&nbsp;extra-lymphatic organs or tissues</p>\n<p>With or without&nbsp;associated lymph node involvement</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">Additionally classified as:\n<p><strong>A</strong> - Asymptomatic</p>\n<p><strong>B &nbsp;-&nbsp;</strong>Any of the following symptoms:</p>\n<ul>\n<li>Absence or incidence of fever &gt;38&deg;C (100.4&deg;F) for 3 consecutive days</li>\n<li>Drenching night sweats</li>\n<li>Unexplained loss of &gt;10% of body weight in the 6 months&nbsp;</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2828",
      "difficulty": "medium"
    },
    {
      "text": "A 49-year-old man is diagnosed with stage IIIB Hodgkin's lymphoma. Lab investigations reveal a hemoglobin of 10.8 g/dl, WBC count of 14,000/ µL, and an absolute lymphocyte count of 450/ µL. Which of the following are poor prognostic factors in this patient?<div class='question-desc-html'><ol>\n<li>Age</li>\n<li>Gender</li>\n<li>Hemoglobin</li>\n<li>WBC count</li>\n<li>Absolute lymphocyte count</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 5"
        },
        {
          "id": 3,
          "text": "3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 2, 4"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In this patient with advanced-stage <strong>Hodgkin's lymphoma</strong>, his age, gender, and absolute lymphocyte count all indicate <strong>poor prognosis</strong>. </p>\n<p>Unfavourable or poor prognostic factors for <strong>advanced-stage </strong>HL (stages III and IV) include: </p>\n<ul>\n<li><strong>Age</strong> <strong>&gt; 45</strong> years</li>\n<li><strong>Male</strong> gender</li>\n<li>Haemoglobin (<strong>Hb</strong>) <strong>&lt; 10.5</strong> <span class=\"nowrap\">g/dL</span></li>\n<li><span class=\"nowrap\">Serum albumin &lt;4 g/dL</span></li>\n<li><span class=\"nowrap\">White blood cell (<strong>WBC</strong>) count <strong>≥15,000</strong>/ µL</span></li>\n<li><span class=\"nowrap\">Absolute lymphocyte count (<strong>ALC</strong>) <strong>&lt; 600</strong>/ µL</span></li>\n</ul>\n<p>Unfavourable or poor prognostic factors for <strong>early Hodgkin's lymphoma</strong> (stages I and II) include: </p>\n<ul>\n<li>Large mediastinal lymphadenopathy</li>\n<li>Involvement of 4 or more sites</li>\n<li>Age &gt;45</li>\n<li>ESR &gt; 30 mm/hr</li>\n<li>B symptoms - unexplained fever, night sweats or unexplained weight loss</li>\n</ul>\n<p>The selection of initial treatment for Hodgkin's lymphoma is usually based on presenting stage and prognostic factors.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2807",
      "difficulty": "medium"
    },
    {
      "text": "A 48-year-old man with fever, night sweats, and weight loss is diagnosed with stage IIB Hodgkin's lymphoma. What is the treatment of choice for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "R- CHOP regimen"
        },
        {
          "id": 2,
          "text": "ABVD regimen"
        },
        {
          "id": 3,
          "text": "ABVD regimen + Field radiation"
        },
        {
          "id": 4,
          "text": "R-CHOP  regimen + Field radiation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The patient's age (&gt; 45 years) and presence of B symptoms indicate an <strong>unfavourable prognosis</strong>. The treatment of choice in <strong>early-stage Hodgkin's</strong> lymphoma (stage I and II) with an unfavourable prognosis is&nbsp;<strong>ABVD regimen</strong> along with<strong> field radiation</strong>.&nbsp;ABVD is a combination of doxorubicin (<strong>a</strong>driamycin), <strong>b</strong>leomycin, <strong>v</strong>inblastine, and <strong>d</strong>acarbazine.</p>\n<p>The treatment of Hodgkin's lymphoma is as follows:</p>\n<ul>\n<li>Early Hodgkin's lymphoma (favourable and unfavourable) -&nbsp;ABVD&nbsp;regimen + limited field radiation</li>\n<li><strong>Advanced</strong> Hodgkin's lymphoma - <strong>extended</strong> course of <strong>chemotherapy</strong> with ABVD regimen.</li>\n</ul>\n<p>The <strong>side effects</strong> of this treatment include:</p>\n<ul>\n<li>Doxorubicin - dilated cardiomyopathy</li>\n<li>Bleomycin- interstitial lung disease</li>\n<li>Vinblastine - SIADH, Peripheral neuropathy</li>\n<li>Radiation - hypothyroidism, Lhermitte's syndrome, infertility</li>\n</ul>\n<p>Note: <strong>R-CHOP</strong> regimen is used in the treatment of <strong>Non-Hodgkin's</strong> lymphoma. It is composed of&nbsp;<strong>r</strong>ituximab + <strong>c</strong>yclophosphamide, <strong>d</strong>oxorubicin, vincristine (<strong>o</strong>ncovin) and <strong>p</strong>rednisone.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB4114",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following lymphoid neoplasms is incorrectly matched with its corresponding etiology?",
      "choices": [
        {
          "id": 1,
          "text": "H. pylori infection - Extra nodal marginal cell lymphoma"
        },
        {
          "id": 2,
          "text": "Gluten-sensitive enteropathy - Intestinal T-cell lymphomas"
        },
        {
          "id": 3,
          "text": "Breast implants - Anaplastic large cell lymphoma"
        },
        {
          "id": 4,
          "text": "Human immunodeficiency virus - Lymphoplasmacytic lymphoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Hepatitis C virus (<strong>HCV</strong>) is the etiological agent for <strong>lymphoplasmacytic lymphoma</strong>/ <strong>Waldenstrom's</strong> macroglobulinemia.</p>\n<p>Human immunodeficiency virus (<strong>HIV</strong>) is associated with diffuse large B-cell lymphoma (<strong>DLBCL</strong>) and <strong>Burkitt's</strong>&nbsp;lymphoma.</p>\n<p>Other acquired lymphoid neoplasms include:</p>\n<ul>\n<li>Gastric MALToma/extranodal marginal cell lymphoma - induced by<em> Helicobacter pylori</em> infection&nbsp;</li>\n<li>Intestinal T-cell lymphomas/enteropathy-associated T cell lymphoma - induced by gluten-sensitive enteropathy</li>\n<li>Anaplastic large cell lymphoma in scar tissue - can occur following breast implants&nbsp;</li>\n</ul><p>Breast Implant-Associated Lymphoma is not breast cancer - it is a type of non-Hodgkin's lymphoma. In most cases, BIA-ALCL is found in the scar tissue and fluid near the implant, but in some cases, it can spread throughout the body</p><hr><h3>Related Pearl: Lymphomas with Etiology</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Etiological factor</strong></p>\n</td>\n<td>\n<p><strong>Lymphoid neoplasm</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>Helicobacter pylori</em></p>\n</td>\n<td>\n<p>Gastric MALToma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>EBV</p>\n</td>\n<td>\n<p>Burkitt's lymphoma</p>\n<p>Post&ndash;organ transplant lymphoma</p>\n<p>Primary CNS diffuse large B cell lymphoma</p>\n<p>Hodgkin's disease (Mixed cellularity and lymphocyte depleted)</p>\n<p>Extranodal NK/T cell lymphoma, nasal type</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HIV</p>\n</td>\n<td>\n<p>Diffuse large B cell lymphoma</p>\n<p>Burkitt's lymphoma</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatitis C</p>\n</td>\n<td>\n<p>Lymphoplasmacytic lymphoma (Waldenstrom's macroglobulinemia)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HHV 8</p>\n</td>\n<td>\n<p>Primary effusion lymphoma</p>\n<p>Kaposi sarcoma</p>\n<p>Multicentric Castleman's disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Gluten sensitivity / Celiac disease</p>\n</td>\n<td>\n<p>Enteropathy-associated T-cell lymphoma (small intestine)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Severe T-cell deficiency</p>\n</td>\n<td>\n<p>B-cell lymphomas</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>HTLV-1</p>\n</td>\n<td>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>EBV:&nbsp;Epstein&ndash;Barr virus</p>\n<p>HHV 8: Human herpesvirus-8</p>\n<p>HTLV:&nbsp;Human T-cell leukemia/lymphoma virus&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9613",
      "difficulty": "medium"
    }
  ]
}